Among the successful healthcare innovations by M-EDG’s management:
 |
The first premix in-solution antimicrobial/antibiotic introduced in the U.S. pharmaceutical industry | |
| The first premix therapeutic pharmaceutical product introduced in glass (Abbott) for hospital I.V. systems |
 |
|
 |
The first premix
therapeutic pharmaceutical product introduced
in plastic
(Baxter-Travenol) for hospital I.V. systems |
|
|
The first hospital products private label agreement executed with the largest U.S. hospital system |
 |
|
 |
The first highly effective topical medication for the most prevalent form of gynecological infection/disorder (including the first publishing of the name of this disorder, bacterial vaginosis) | |
| The first anti-infective product effective and safe against many types of serious and typically life-threatening (anaerobic) bacterial infections/disorders. |
|
|
